CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-α release from lipopolysaccharide-treated cells and mice
John R. Ciallella(Stealth BioTherapeutics (United States)), Dorothy G. Flood(Brandywine Photonics (United States))
Cited by 40
Related Papers
CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities
|Journal of Pharmacology and Experimental Therapeutics|2011|58